AR128076A1 - Anticuerpos que reconocen la sortilina - Google Patents
Anticuerpos que reconocen la sortilinaInfo
- Publication number
- AR128076A1 AR128076A1 ARP220103560A ARP220103560A AR128076A1 AR 128076 A1 AR128076 A1 AR 128076A1 AR P220103560 A ARP220103560 A AR P220103560A AR P220103560 A ARP220103560 A AR P220103560A AR 128076 A1 AR128076 A1 AR 128076A1
- Authority
- AR
- Argentina
- Prior art keywords
- antibodies
- sortilin
- recognize
- delay
- changes
- Prior art date
Links
- 102100032889 Sortilin Human genes 0.000 title abstract 2
- 108010014657 sortilin Proteins 0.000 title abstract 2
- 102000019204 Progranulins Human genes 0.000 abstract 1
- 108010012809 Progranulins Proteins 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/286—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/71—Decreased effector function due to an Fc-modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención proporciona anticuerpos que se unen específicamente a la sortilina. Los anticuerpos inhiben o retrasan patologías asociadas con cambios en los niveles de progranulina y el deterioro sintomático asociado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163293588P | 2021-12-23 | 2021-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR128076A1 true AR128076A1 (es) | 2024-03-20 |
Family
ID=86903811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220103560A AR128076A1 (es) | 2021-12-23 | 2022-12-22 | Anticuerpos que reconocen la sortilina |
Country Status (4)
Country | Link |
---|---|
US (1) | US20230348588A1 (es) |
AR (1) | AR128076A1 (es) |
TW (1) | TW202342516A (es) |
WO (1) | WO2023122766A2 (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050100965A1 (en) * | 2003-11-12 | 2005-05-12 | Tariq Ghayur | IL-18 binding proteins |
CA2981851A1 (en) * | 2015-04-07 | 2016-10-13 | Alector Llc | Anti-sortilin antibodies and methods of use thereof |
CN115960235A (zh) * | 2015-08-28 | 2023-04-14 | 艾利妥 | 抗siglec-7抗体及其使用方法 |
CN116693686A (zh) * | 2018-02-11 | 2023-09-05 | 江苏豪森药业集团有限公司 | 抗b7-h4抗体、其抗原结合片段及其医药用途 |
CN116249717A (zh) * | 2020-06-24 | 2023-06-09 | 普罗塞纳生物科学有限公司 | 识别分拣蛋白的抗体 |
-
2022
- 2022-12-22 US US18/145,588 patent/US20230348588A1/en active Pending
- 2022-12-22 AR ARP220103560A patent/AR128076A1/es unknown
- 2022-12-22 TW TW111149501A patent/TW202342516A/zh unknown
- 2022-12-22 WO PCT/US2022/082299 patent/WO2023122766A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023122766A2 (en) | 2023-06-29 |
WO2023122766A3 (en) | 2023-08-17 |
US20230348588A1 (en) | 2023-11-02 |
TW202342516A (zh) | 2023-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018012986A2 (es) | Anticuerpos que reconocen tau | |
CO2021011140A2 (es) | Anticuerpos que reconocen tau | |
CO2021011644A2 (es) | Anticuerpos que reconocen tau | |
CO2019013265A2 (es) | Anticuerpos que reconocen tau | |
CO2018012987A2 (es) | Anticuerpos que reconocen tau | |
CO2021007370A2 (es) | Anticuerpos que reconocen tau | |
CU24446B1 (es) | Un anticuerpo monoclonal humanizado que se une a tau | |
CU20210039A7 (es) | Anticuerpos que reconocen tau | |
UA45061S (uk) | 1. футляр | |
AR122736A1 (es) | Anticuerpos que reconocen sortilina | |
AR128076A1 (es) | Anticuerpos que reconocen la sortilina | |
JP2021101083A5 (es) | ||
UA44765S (uk) | 1. тверде паливо особливе | |
UA46360S (uk) | 1. всюдихід | |
JP1745428S (ja) | 書類ケース | |
JP1745429S (ja) | 書類ケース | |
JP1745431S (ja) | 書類ケース | |
JP1752306S (ja) | 書類ケース | |
TR201903527U5 (tr) | Follukta yeni̇li̇k | |
UA46013S (uk) | 1. боєприпас | |
UA45979S (uk) | 1. каналізаційний люк | |
UA45901S (uk) | 1. каналізаційний люк | |
UA45870S (uk) | 1. церква | |
UA46361S (uk) | 1.-2. всюдихід | |
UA45476S (uk) | 1.-3. годинник наручний |